Exubera Replacement Devices Will Be Offered Under Pfizer Program
This article was originally published in The Pink Sheet Daily
Company asks patients to return broken devices so it can determine “what the problem is.”
You may also be interested in...
Pfizer will roll out an education program for physicians and patients at the end of July and will launch the inhaled insulin in September.
Singapore-based institute is also looking at dengue fever and malaria, exec says in interview with “The Pink Sheet” DAILY.
Lilly will pay up to $500 million to settle the "vast majority" of claims alleging that the company failed to adequately warn patients of risks associated with the atypical antipsychotic Zyprexa (olanzapine), the firm announced Jan. 4